<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5A393419-8F67-4FB5-9D17-B9A04A7B3CA9"><gtr:id>5A393419-8F67-4FB5-9D17-B9A04A7B3CA9</gtr:id><gtr:name>University of New South Wales</gtr:name><gtr:address><gtr:line1>Gate 9 High St</gtr:line1><gtr:line2>Kensington</gtr:line2><gtr:line4>Sydney</gtr:line4><gtr:line5>NSW 2052</gtr:line5><gtr:postCode>2052</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6ADBF30E-89E6-4512-BC58-128CD5A537FD"><gtr:id>6ADBF30E-89E6-4512-BC58-128CD5A537FD</gtr:id><gtr:name>ICNARC Case Mix Programme</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/15C3D27C-F36B-4991-B276-377EA25E7FBF"><gtr:id>15C3D27C-F36B-4991-B276-377EA25E7FBF</gtr:id><gtr:name>University Clinic Golnik</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61542A68-1EF5-468B-A225-741B3363228E"><gtr:id>61542A68-1EF5-468B-A225-741B3363228E</gtr:id><gtr:name>Netherlands Organization for Applied Scientific Research (TNO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6ADBF30E-89E6-4512-BC58-128CD5A537FD"><gtr:id>6ADBF30E-89E6-4512-BC58-128CD5A537FD</gtr:id><gtr:name>ICNARC Case Mix Programme</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/15C3D27C-F36B-4991-B276-377EA25E7FBF"><gtr:id>15C3D27C-F36B-4991-B276-377EA25E7FBF</gtr:id><gtr:name>University Clinic Golnik</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF9D180E-7AAF-479F-8D6A-91239520D6C2"><gtr:id>FF9D180E-7AAF-479F-8D6A-91239520D6C2</gtr:id><gtr:name>Zoology Ecology and Plant Science</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/04500B3A-1219-4E25-96B6-5AFBA5839CAA"><gtr:id>04500B3A-1219-4E25-96B6-5AFBA5839CAA</gtr:id><gtr:name>French National Institute of Agricultural Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5A393419-8F67-4FB5-9D17-B9A04A7B3CA9"><gtr:id>5A393419-8F67-4FB5-9D17-B9A04A7B3CA9</gtr:id><gtr:name>University of New South Wales</gtr:name><gtr:address><gtr:line1>Gate 9 High St</gtr:line1><gtr:line2>Kensington</gtr:line2><gtr:line4>Sydney</gtr:line4><gtr:line5>NSW 2052</gtr:line5><gtr:postCode>2052</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61542A68-1EF5-468B-A225-741B3363228E"><gtr:id>61542A68-1EF5-468B-A225-741B3363228E</gtr:id><gtr:name>Netherlands Organization for Applied Scientific Research (TNO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B2908F5F-285C-4EAB-B2AF-9DF9097E1553"><gtr:id>B2908F5F-285C-4EAB-B2AF-9DF9097E1553</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Justin</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK010468%2F1"><gtr:id>2E9D9C97-BD30-42FE-BA12-8D117156B6C8</gtr:id><gtr:title>Mechanisms underlying the physiological and cellular response to food allergen challenge in human subjects with peanut allergy</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/K010468/1</gtr:grantReference><gtr:abstractText>Food allergy affects up to 2% of adults and 8% of children in the UK, and can cause life-threatening reactions (anaphylaxis) in some but not all individuals. The mainstay of management remains dietary avoidance. There is no effective treatment for preventing allergic reactions, which can be fatal even when rescue medication is given in a timely manner.

Allergic reactions to food are mediated through the Immunoglobulin E (IgE) antibody. The binding of allergenic proteins in food to IgE causes the release of different chemical mediators, including histamine. Much of our knowledge of the mechanism is derived from animal models, but this may not be representative of the situation in man. Antihistamines can prevent fatality in animal models of anaphylaxis but are much less effective in man, possibly because humans are 1000-fold more sensitive to the effects of histamine than, for example, mice. Furthermore, anaphylaxis in peanut-allergic humans can be triggered by tiny amounts of protein (under 10mg or 1/30 of a single peanut). By comparison, very high levels are required to cause anaphylaxis by the oral route in mouse models, equivalent to a person eating over 1000 peanuts. These examples demonstrate the difficulties of extrapolating data from animal models to man.

The diagnosis of food allergy can be confirmed by the detection of specific IgE to the trigger food, either by blood or skin testing. Unfortunately, while levels of specific IgE predict the likelihood of reaction after exposure, they do not predict the severity of reaction. While some risk factors have been identified for anaphylaxis (e.g. asthma, underlying heart disease, previous anaphylaxis), the majority of patients do not have a risk factor. Health professionals are therefore unable to determine who is at risk of anaphylaxis, resulting in widespread prescribing of adrenaline auto-injector pens for emergency rescue treatment. The prescription of these devices has increased over the past decade, from 74,600 devices in England in 2000 to over 230,000 devices in 2010, at a cost of &amp;pound;12.5m. The vast majority of these devices are never used, and their prescription is a significant cost to the health service. Any data facilitating improved risk stratification of allergic individuals would assist health professionals in providing reassurance to patients and parents alike, as well as delivering economic savings.

Given the importance of dietary avoidance in the management of food allergies, the Food Standards Agency (FSA) is commissioning a study to determine the amount of peanut which needs to be consumed to trigger a reaction. This threshold varies significantly between individuals, but also within the same person, depending on a number of poorly understood factors including exercise. The aim is to define a safe level of potential food contamination below which peanut-allergic individuals will not react, thus informing the food industry and better protecting the allergic population. The study will recruit 100 peanut-allergic volunteers, each undergoing controlled exposure to peanut or placebo under medical supervision on different occasions.

The FSA study provides a unique opportunity to assess the mechanism of food allergic reactions, and determine the extent to which data from animal models are applicable to man. We propose to monitor the effects of food allergic reactions on:
- the absorption of food proteins in the mouth, to see if this changes as the reaction progresses
- the release of different chemical mediators in blood, saliva and urine.
- changes in blood flow, both at the site of reaction and beyond, using non-invasive techniques

Our data will provide valuable insight into the mechanisms underlying food allergic reactions in man, highlighting new targets for future diagnostic tests and therapies. We further plan to develop new strategies to improve risk stratification, in order to improve management of peanut allergic individuals.</gtr:abstractText><gtr:technicalSummary>AIMS
1) To investigate the pathophysiology of acute allergic reactions to peanut, and how this relates to severity of clinical symptoms, by assessing mucosal absorption of allergen, cellular activation and vascular physiology.
2) To understand the process by which exercise may alter the character of food allergic reactions.

METHODS
This fellowship will capitalize on a recently funded trial involving repeated double-blind placebo-controlled food challenge (DBPCFC) of peanut-allergic adults under controlled conditions. We will assess mechanisms of the acute reaction to a food allergen through:
- assays for biomarkers (blood, saliva, urine) including kinins, complement, leukotrienes and mast cell proteases. Leukocyte activation will be determined by poylchromatic flow cytometry
- Assessment of local and systemic changes in vascular flow and permeability, using established non-invasive techniques
- the above techniques will be repeated with DBPCFC after exercise

SCIENTIFIC AND MEDICAL OPPORTUNITIES
1) Investigate how the pathophysiology of acute allergic reactions to food differs from that of non-food triggers, which are not often associated with systemic effects. This will highlight new targets for future therapeutic interventions, as well as facilitate risk stratification of peanut allergic individuals
2) Determine the extent to which animal models of food allergy are applicable to man.
3) Allow for characterisation of peanut allergic individuals in terms of peanut-specific antibody production (IgE, IgG, IgG4, IgA, free Ig light chain) and how this relates to reaction severity
4) Validation of novel salivary markers of allergic reactions, improving diagnostic opportunities in patients in whom diagnosis is unclear
5) Synergistic collaborations with the pan-European project on Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM), which will investigate intrinsic and extrinsic factors affecting the severity of reactions to foods.</gtr:technicalSummary><gtr:potentialImpactText>1. Health and Social Outputs : Individuals

Study participants: will benefit directly from an awareness of their symptoms and the amount of food allergen needed to trigger this. Previous studies have demonstrated that patients undergoing diagnostic food challenges report an improvement in quality of life measures within a short timeframe (months), even where the challenge is 'positive'.

Patients and their families: Up to 8% of children and 2% of adults in the UK have food allergies; this has a high impact on a patient's quality of life, along with their carers (e.g. parents of affected children). This study will complement the results from the threshold-determining study, by providing additional data relating to the allergic reaction, and whether levels of exposure around the threshold cause reproducible reactions in terms of symptom severity. This will inform policy relating to allergen labelling of foods in terms of potential cross-contamination, resulting in benefits to the wider food-allergic population in the UK. It is hoped that this will take place within 3-5 years. Longer-term, the study will highlight future therapeutic targets which may be useful in the future management of severe reactions. 

Health professionals: will be better able to offer reassurance to those affected by food allergies, on the basis of a greater understanding of mechanisms involved and improved tools to determine who is at risk of severe symptoms. The validation of diagnostic techniques for food allergic reactions (e.g. salivary testing) will be of particular utility for professionals in the emergency services and A&amp;amp;E departments. These benefits should commence within the period of this grant, once results have been published in peer-reviewed journals.

2. Health and Social Outputs : Public Services and Health Policy

UK &amp;amp; Europe Policy makers: The results will be used to inform data relating to Minimal Eliciting Doses for the food-allergic population and the required safety factor, in order to inform industry and with a view to protecting the allergic population. This has been determined to be a priority by the Food Standards Agency (FSA). Through my proposed collaboration in the EU-funded project on Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM), there will also be significant benefits to EU policy makers.

Health policy: Improved risk stratification of peanut-allergic individuals will allow a more targeted provision of education and rescue medications (such as adrenaline autoinjector devices), with associated cost benefits.

Voluntary sector: A number of support groups and charities have been established to support food-allergic patients and their families. Food allergy has a high impact on quality of life measures. By providing information relating to risk assessment and allergen avoidance, the study will empower these groups to provide more comprehensive information to allergic individuals in the UK, within a timeframe similar to that of the publication of the study results (as described above).

3. Economic benefits : National and Global

Food allergy is increasing throughout the world, and is now a global issue, particularly with the export of foods from one country to another. Some countries (e.g. Australia) have already attempted to rationalise allergen labelling of foods in order to provide clearer information to consumers, though the success of this initiative is debatable. Europe, and in particular the FSA, are taking a more quantitative, evidence-based approach. In conjunction with good manufacturing practice, this initiative can be expected to provide a competitive advantage in the provision of foods with appropriate labelling for allergy sufferers. European researchers are leading the world in advancing this important area of investigation.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1244522</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>ICNARC Case Mix Programme</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ICNARC</gtr:description><gtr:id>7FA37672-5E1C-4F0C-8D0C-9596AE75C2A8</gtr:id><gtr:impact>Funding application (submitted)</gtr:impact><gtr:outcomeId>56b4a00236db36.29931177-1</gtr:outcomeId><gtr:partnerContribution>Joint funding application to analysis ICU admissions due to anaphylaxis in England and Wales</gtr:partnerContribution><gtr:piContribution>Joint funding application to analysis ICU admissions due to anaphylaxis in England and Wales</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Inflammation and Repair</gtr:department><gtr:description>iFAAM</gtr:description><gtr:id>DDD942FD-22AC-4206-A725-F5E44B25CD2A</gtr:id><gtr:impact>2 review articles (one published to date, one under review)</gtr:impact><gtr:outcomeId>RhWcJKMaEyf-1</gtr:outcomeId><gtr:partnerContribution>Synergies with regards to severity score</gtr:partnerContribution><gtr:piContribution>1) Development of a severity score system for food-induced allergic reactions
2) Strategic approaches to 'may contain' precautionary statements on food labels</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>French National Institute of Agricultural Research</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>INRA</gtr:description><gtr:id>BB30DF52-1B1F-46FB-8538-84D61BC7CE51</gtr:id><gtr:impact>Pilot data</gtr:impact><gtr:outcomeId>544a5fd57a2c32.27318260-1</gtr:outcomeId><gtr:partnerContribution>Laboratory analysis of food proteins in biological samples</gtr:partnerContribution><gtr:piContribution>Supply of biologicial samples for laboratory analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of New South Wales</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Faculty of Engineering</gtr:department><gtr:description>UNSW</gtr:description><gtr:id>5249E95C-4715-4312-BD30-0E2EA75DA6BE</gtr:id><gtr:impact>Nil to date - collaboration only just commenced</gtr:impact><gtr:outcomeId>58a0935aa191c9.67001990-1</gtr:outcomeId><gtr:partnerContribution>IgE-immunoblot changes during desensitisation in peanut allergy</gtr:partnerContribution><gtr:piContribution>Provision of samples and clinical data relating to peanut-allergic individuals, to assess IgE-immunoblot changes during desensitisation in peanut allergy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PHE</gtr:description><gtr:id>7248C7F4-966E-4948-A286-BCD2635CD782</gtr:id><gtr:impact>Report to MHRA x 2. 4 conference abstracts. Change in UK vaccination policy achieved. Further study funded. 3 x papers published.</gtr:impact><gtr:outcomeId>5448f5b870a8a2.74861155-1</gtr:outcomeId><gtr:partnerContribution>Funding and statistical support</gtr:partnerContribution><gtr:piContribution>Head of collaboration for multicentre CTIMP assessing safety of egg-containing vaccine in egg-allergic children including those with history of severe allergic reactions</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Manchester University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Anaphylaxis Registry</gtr:description><gtr:id>AD02F6BC-53BF-48A6-89BA-7F119D381A2C</gtr:id><gtr:impact>Publication pending</gtr:impact><gtr:outcomeId>KtE6Gd6gHyR-1</gtr:outcomeId><gtr:partnerContribution>Review and cleaning of existing UK fatal anaphylaxis data, collection of prospective data</gtr:partnerContribution><gtr:piContribution>Review and cleaning of existing UK fatal anaphylaxis data, collection of prospective data</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Inflammation and Repair</gtr:department><gtr:description>TRACE</gtr:description><gtr:id>2D15E3A1-214A-4563-B19F-AF6B7BB803E8</gtr:id><gtr:impact>nil to date</gtr:impact><gtr:outcomeId>Qv1cZUxUosP-1</gtr:outcomeId><gtr:partnerContribution>Resources in order to fund and excecute DBPCFC food challenges in allergic adults</gtr:partnerContribution><gtr:piContribution>Mechanistic investigations to food allergic reactions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Cork</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>UCC</gtr:description><gtr:id>EE753E7B-11A9-4E44-948C-183553A74BF5</gtr:id><gtr:impact>Plans for a pan-European survey to assess consumer approaches to allergen labelling interpretation</gtr:impact><gtr:outcomeId>56b4926b77d886.52885984-1</gtr:outcomeId><gtr:partnerContribution>Data relating to reaction thresholds, interpretation of food allergen labels, research methodology, data analysis</gtr:partnerContribution><gtr:piContribution>Data relating to reaction thresholds, interpretation of food allergen labels, research methodology, survey.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Hospital of Philadelphia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Allergy</gtr:department><gtr:description>CHOP</gtr:description><gtr:id>25E5343F-C177-4AEF-BAD1-0B03FF82B128</gtr:id><gtr:impact>nil to date - collaboration only just commenced</gtr:impact><gtr:outcomeId>58a0943c88a317.95772922-1</gtr:outcomeId><gtr:partnerContribution>Successful award of a grant from the EAT foundation (USA) to look at transcriptomics during peanut-induced allergic reactions: analysis of blood samples.</gtr:partnerContribution><gtr:piContribution>Successful award of a grant from the EAT foundation (USA) to look at transcriptomics during peanut-induced allergic reactions: provision of blood samples, clinical data and analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Netherlands Organization for Applied Scientific Research (TNO)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>TNO</gtr:description><gtr:id>B26AFB80-0131-49CC-B290-7184BBB8AB65</gtr:id><gtr:impact>Conference abstract. Paper in submission.</gtr:impact><gtr:outcomeId>56b48a14db38e1.39808069-1</gtr:outcomeId><gtr:partnerContribution>TNO have provided analysis for data relating to food allergen thresholds and the effect of food processing on these.</gtr:partnerContribution><gtr:piContribution>Contributed with data and methodology towards risk assessment methodology for food industry with respect to food allergens. Negotiations are underway to fund a 2 year MD project at Imperial College London.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TRACE</gtr:description><gtr:id>CA6A00D4-353C-4C5B-9D4A-891CA02B0A31</gtr:id><gtr:impact>nil to date</gtr:impact><gtr:outcomeId>Qv1cZUxUosP-2</gtr:outcomeId><gtr:partnerContribution>Resources in order to fund and excecute DBPCFC food challenges in allergic adults</gtr:partnerContribution><gtr:piContribution>Mechanistic investigations to food allergic reactions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Clinic Golnik</gtr:collaboratingOrganisation><gtr:country>Slovenia, Republic of</gtr:country><gtr:description>Pero Korosec, Slovenia</gtr:description><gtr:id>B4D117FA-7061-47E4-9F84-EFEBD91EB345</gtr:id><gtr:impact>1 Accepted manuscript to J. Allergy Clin Immunol., to date.</gtr:impact><gtr:outcomeId>58a0927e112550.67733219-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples and data from patients undergoing acute allergic reactions to venom, presenting to the emergency department, to determine pathophysiological changes during allergic reactions</gtr:partnerContribution><gtr:piContribution>Provision of samples and data from food challenges to peanut, to determine pathophysiological changes during allergic reactions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>USyd</gtr:description><gtr:id>95CF9B49-C079-47D7-9EC6-9CCAB478797A</gtr:id><gtr:impact>pending</gtr:impact><gtr:outcomeId>544a715286d916.22181281-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, provision of IMP equivalent, lab analysis</gtr:partnerContribution><gtr:piContribution>Joint clinical study: pilot study being performed in London, UK with analysis of samples and future 2 centre study involving UK and Australia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Updated info sheets: Anaphylaxis Campaign</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>73D3A3DE-8E7C-4BE5-AE32-8F1CDCC36DFD</gtr:id><gtr:impact>Edited information sheet (online) for Anaphylaxis Campaign</gtr:impact><gtr:outcomeId>58a098df011bb9.06294833</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Generic adrenaline autoinjectors / MHRA</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BE4F2435-E783-4235-AEFC-BBE762611435</gtr:id><gtr:impact>Working group to work with DoH/MHRA to facilitate change in UK legislation allowing generic adrenaline autoinjectors into schools</gtr:impact><gtr:outcomeId>58a098034abc68.64850789</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NRP Radio interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AB653BFA-B13F-425D-A620-1C5B1B8A68A2</gtr:id><gtr:impact>Radio interview with NRP Washington to discuss management of anaphylaxis, and in particular, use of adrenaline autoinjectors</gtr:impact><gtr:outcomeId>58a096c375a693.72018876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ILSI Severity</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>65836F42-A6EC-400B-88C8-50708395789D</gtr:id><gtr:impact>Ongoing ILSI expert group on assessing relationship between exposure dose and severity of resulting allergic reactions, to inform allergen risk management</gtr:impact><gtr:outcomeId>56b49465d6f2e0.09055113</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.ilsi.org/Europe/Pages/Food-Allergy-Expert-Groups.aspx</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Akademie Fresenius</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D0919E99-0475-4B13-9E81-D107492BC8DB</gtr:id><gtr:impact>2 day workshop / expert panel on improving allergen risk management in food industry</gtr:impact><gtr:outcomeId>56b4933a312c73.63907118</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>https://www.akademie-fresenius.com/company/press/news-details/eliminationsdiaet-bei-lebensmittelallergien-zwingend-notwendig/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Food Matters</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7EA12B9-F205-44DD-AD44-40C1E7E81F16</gtr:id><gtr:impact>Food Matters Live meeting at Excel - presentation on allergy labelling to general public with Q&amp;amp;A afterwards</gtr:impact><gtr:outcomeId>56b495ebbe1e33.63652033</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC 4</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DA669A32-4817-403C-BF6C-A73CC23063EC</gtr:id><gtr:impact>Filming for a BBC documentary on blood and allergy

Film yet to be aired</gtr:impact><gtr:outcomeId>544a6c1dc2d104.26266829</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EAACI Severity meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>40CF7FDE-713C-40A4-B054-62AABF15967C</gtr:id><gtr:impact>Invovled in European working group on anaphylaxis diagnosis and management

pending</gtr:impact><gtr:outcomeId>544a70aa2ba5b4.51527923</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FSA Adult allergy</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9E1577B7-B4DC-4CB4-B6AA-47A67E3C99D9</gtr:id><gtr:impact>Scoping group to define research strategy for Food Standards Agency</gtr:impact><gtr:outcomeId>56b49588170a00.35080371</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ITV regional news</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4862C690-E4BD-4EB0-96CF-DC83520B233A</gtr:id><gtr:impact>Filmed for brief slot on allergy awareness week for ITV regional news

none specific</gtr:impact><gtr:outcomeId>544a6cae427ea2.81795669</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=d86SRfBk1s4</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Working group: FPIES</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3CB8A013-FA18-4FA0-B91B-14CC32CF6B06</gtr:id><gtr:impact>International guidelines on the management of FPIES</gtr:impact><gtr:outcomeId>58a0978d65a086.79089032</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.jacionline.org/article/S0091-6749(17)30153-7/fulltext</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>iFAAM Food labelling</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB4E79EE-E613-4F17-89B8-3DFF3A4F650A</gtr:id><gtr:impact>80 stakeholders attended a 1 day iFAAM/ILSI workshop on improving allergen food labelling. Feedback useful in determining ongoing activities.</gtr:impact><gtr:outcomeId>56b491a2e1b3b4.32066063</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Anaphylaxis Campaign support group</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4FC26FA1-35A6-45EB-8FF1-A3A56DAC9888</gtr:id><gtr:impact>15 parents of food allergic children

Follow up from 2 parents seeking further information</gtr:impact><gtr:outcomeId>Zu84kyX9JA7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>180050</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>End Allergies Together</gtr:fundingOrg><gtr:id>B6158B65-B6DA-4F70-B159-1013767E6704</gtr:id><gtr:outcomeId>58a095dc8d09e9.74571352</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55426</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Confidence in Concept Scheme</gtr:department><gtr:description>MRC Confidence in Concepts Award</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>ICL PS2531_WMNP and PS2563_WMNP</gtr:fundingRef><gtr:id>DF05C29D-4C6B-49F5-846B-52F1531510D2</gtr:id><gtr:outcomeId>56b48b2009cf47.93224026</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Vaccine Evaluation Consortium, Department of Health</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Public Health England</gtr:fundingOrg><gtr:fundingRef>039/0031</gtr:fundingRef><gtr:id>AC8B65B3-9EA8-4E2B-AAFC-2E9D877BAF41</gtr:id><gtr:outcomeId>56b48d20e79e13.46229598</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>55400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Confidence in Concept Scheme</gtr:department><gtr:description>MRC Confidence in Concepts Award</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>ICL P50832</gtr:fundingRef><gtr:id>DDE017C2-F682-45BA-943A-7B6642D5D9E0</gtr:id><gtr:outcomeId>544a698acf1203.37069405</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 iFAAM collaboration</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>312147</gtr:fundingRef><gtr:id>38FEB03A-A525-4222-AC97-2DF6ED9C8EE8</gtr:id><gtr:outcomeId>56b48ec4a502b2.33262822</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Vaccine Evaluation Consortium, Department of Health</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Public Health England</gtr:fundingOrg><gtr:fundingRef>039/0031</gtr:fundingRef><gtr:id>05DAD30D-8586-472B-9A64-91B0D2B28416</gtr:id><gtr:outcomeId>mNhpy1KDKuR</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>153000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>BRC Funding</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>3AC3FB3C-F5E0-4538-AC44-9241476D6465</gtr:id><gtr:outcomeId>544a69e720d7d2.46775910</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE Diagnostic Assessment</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>61E27555-64D6-4090-B01F-F6FEFCC82AFF</gtr:id><gtr:outcomeId>56b499fdd90861.12847738</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>COT</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2E64074B-086C-4DA4-934C-690F1F0FD5AD</gtr:id><gtr:impact>Invited to be expert member to the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT), an independent scientific committee that provides advice to the Food Standards Agency, the Department of Health and other Government Departments and Agencies on matters concerning the toxicity of chemicals. Remit relates to a review by COT of strategies which might affect atopic outcomes in pregnancy/children/adulthood.</gtr:impact><gtr:outcomeId>56b499cbed0d79.06400308</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Generic AAI</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F986BD6D-B3BC-4E59-9C53-89EA66CA3120</gtr:id><gtr:impact>Member of steering group which has worked and lobbied DoH and MHRA for a change in UK legislation to allow generic adrenaline autoinjectors in schools and other educational settings. This MHRA have agreed to a change in legislation and we are working with a variety of stakeholder groups including DH and D.Ed. to provide national guidance to schools in the management of allergic reactions and the use of the generic adrenaline.</gtr:impact><gtr:outcomeId>58a4035137a7b2.13698047</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://www.anaphylaxis.org.uk/campaigning/generic-pen-campaign/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Public Health England / Dept Health</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>97BC4AD2-0FC3-4788-B167-D20E270BFEB4</gtr:id><gtr:impact>Asked to advise DoH re National Vaccination Policy with respect to influenza vaccination. Data from research on which I have led has been used to inform UK guideliness.</gtr:impact><gtr:outcomeId>rhheLsFxBqz</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>UCT Paediatric Allergy/PICU meeting</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>2D0D16E4-C4EC-4635-A14A-454418C7194C</gtr:id><gtr:impact>Guest speaker/trainer at National Paediatric Training meeting in S. Africa, which attracted HCPs from across Africa as well as from South Africa. I gave 3 sessions on diagnosis/management of anaphylaxis, with a number of approaches afterwards to discuss improvements in the clinical management of anaphylaxis.</gtr:impact><gtr:outcomeId>58a4058f4ca856.81309347</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>JCVI / Dept of Health</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D2036585-019A-4678-9086-D76084BD12F2</gtr:id><gtr:impact>Asked to advise the Joint Committee on Vaccination and Immunisation (JCVI) which advises UK health departments on immunisation relating to influenza.</gtr:impact><gtr:outcomeId>56b4991bcd85c9.89180363</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FSA</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1D538799-0B69-482D-8D84-347D827A0FD7</gtr:id><gtr:impact>Involved in a UK Food Standards Agency review programme for allergen management in industry</gtr:impact><gtr:outcomeId>544a72680d2818.08262661</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>FSA Science Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2C9E2C83-AA0E-426A-9014-BD04A32DDE7D</gtr:id><gtr:impact>I have been appointed as one of seven members of the UK Food Standards Agency Science Council. The Council will provide high-level, expert and independent advice and challenge to the Agency on how it uses science to underpin its work.</gtr:impact><gtr:outcomeId>58c5aed3c8bd28.30850016</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>https://www.food.gov.uk/committee/science-council/news-updates/news/2017/16036/appointments-to-the-science-council</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Safety of Fluenz (intranasal influenza vaccine in children with egg allergy +/- asthma</gtr:description><gtr:id>45B37368-8CDB-4367-B66C-D793318EEF2F</gtr:id><gtr:impact>change in UK public vaccination policy</gtr:impact><gtr:outcomeId>544a741eddc9a3.53722488</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Fluenz (LAIV)</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:url>http://clinicaltrials.gov/show/NCT02111512</gtr:url><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Efficacy and safety of Fluenz (intranasal influenza vaccine) in atopic children</gtr:description><gtr:id>96BC4658-098D-4FC1-915E-F8616374FA1D</gtr:id><gtr:impact>Data has supported change in national vaccine policy</gtr:impact><gtr:outcomeId>56b4a2069cb215.25112285</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Fluenz (LAIV)</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:url>https://clinicaltrials.gov/ct2/show/NCT02549365</gtr:url><gtr:yearDevCompleted>2015</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Phase 2/3 RCT to evaluate use of modified peanut allergen in oral immunotherapy for peanut allergy</gtr:description><gtr:id>3B0207F2-28D6-4DC6-9A1F-5F78BA221A45</gtr:id><gtr:impact>The pilot data has led to a AUD$1.6million award from NHMRC for a follow-on study, on which I am a co-I.</gtr:impact><gtr:outcomeId>56b4b4bb8a3df5.70399294</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>BOPI</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>https://clinicaltrials.gov/ct2/show/NCT02149719</gtr:url><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>SNIFFLE-4 Study is a nationwide, multicentre study assessing the safety of Fluenz Tetra in children with moderate-severe asthma. The vaccine is currently available in UK and is part of the national childhood immunisation schedule. However, it's use in asthma is a relative contra-indication. I am the national CI on the study.</gtr:description><gtr:id>2E9BA408-DE9C-4667-BD4B-881CC4D6740D</gtr:id><gtr:impact>The study results will feed directly in PHE guidance for influenza vaccination.</gtr:impact><gtr:outcomeId>58a4093e85e975.33279311</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Fluenz Tetra (LAIV)</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Assessing safety of Fluenz LAIV immunisation in egg-allergic children; DoH funded.</gtr:description><gtr:id>551F2CAC-C67B-4EB2-9D96-BE00ED8EDB57</gtr:id><gtr:impact>Demonstration of safety of Fluenz vaccination in egg-allergic children, facilitating nationwide roll-out of universal flu vaccination in children improving streamlined delivery of vaccination programme.</gtr:impact><gtr:outcomeId>GiAnRF3vnV5</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>SNIFFLE Study</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:url>http://clinicaltrials.gov/show/NCT01859039</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>UK National Register of Fatal Anaphylaxis</gtr:description><gtr:id>7D5DEA9E-9AA0-4321-B582-C53A64A12857</gtr:id><gtr:impact>Publications highlighting risk factors for severe food allergic reactions. Pilot data for case-control study to identify risk factors of severity in food allergy.</gtr:impact><gtr:outcomeId>544a73113150e0.49696626</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anaphylaxis registry</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2D7B76E6-1ED6-49C4-97FA-DA95EF51EB52</gtr:id><gtr:title>Precautionary labelling of foods for allergen content: are we ready for a global framework?</gtr:title><gtr:parentPublicationTitle>The World Allergy Organization journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e3c3b97aeea9f0a3108476fe01393f8"><gtr:id>5e3c3b97aeea9f0a3108476fe01393f8</gtr:id><gtr:otherNames>Allen KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1939-4551</gtr:issn><gtr:outcomeId>5448f1f68b29e9.15964503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>949C489E-3F88-4C8E-845F-5AA83E9E2947</gtr:id><gtr:title>Management of pollen food and oral allergy syndrome by health care professionals in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1081-1206</gtr:issn><gtr:outcomeId>5675e0d62d705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E23CBE2-C8BA-4832-B48B-257F1E48FAED</gtr:id><gtr:title>No Association Between Atopic Outcomes and Pertussis Vaccine Given in Children Born on the Isle of Wight 2001-2</gtr:title><gtr:parentPublicationTitle>Journal of Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51285d01c4f7abca9a1a2c3b54f49928"><gtr:id>51285d01c4f7abca9a1a2c3b54f49928</gtr:id><gtr:otherNames>Venter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b58844a43d6.53299127</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7AA7D1D-6874-4F40-8929-F9A9D714C2E0</gtr:id><gtr:title>Precautionary allergen labelling: NO MORE TRACES!</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>585d38f1261f14.18553266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55987111-C9FA-4FAE-9C84-6E41F09198E5</gtr:id><gtr:title>Knowledge, practice, and views on precautionary allergen labeling for the management of patients with IgE-mediated food allergy--a survey of Australasian and UK health care professionals.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56a7ed96dac2d4.56228426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D179BEE3-7D36-4075-9695-A0DAEB0D3EAE</gtr:id><gtr:title>Precautionary allergen labelling: perspectives from key stakeholder groups.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2cdc9cf17fcbff5e372c6e2bdc1e048"><gtr:id>c2cdc9cf17fcbff5e372c6e2bdc1e048</gtr:id><gtr:otherNames>DunnGalvin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56a7f20d0f43e7.99255718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A636D4DF-5F92-4E8D-BAB2-56995BFA449B</gtr:id><gtr:title>Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d4715143d239cf6514d76f4913f804e"><gtr:id>7d4715143d239cf6514d76f4913f804e</gtr:id><gtr:otherNames>Korosec P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5a578b9b748f85.55728091</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BADF2F2D-89B5-469A-AE90-0DFFB5D4AE3D</gtr:id><gtr:title>Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30cc7c53db4ac24f42cf1cc6fe72ed93"><gtr:id>30cc7c53db4ac24f42cf1cc6fe72ed93</gtr:id><gtr:otherNames>Umasunthar T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>pm_23369_29_24118190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F47AF7-46ED-4603-9538-EF0C62E249F7</gtr:id><gtr:title>Persistent allergy to cow's milk: of greater a clinical concern than other food allergies.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>pm_23369_29_24112423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8C3D6FB-3ED0-4A04-AB49-37CD70433A50</gtr:id><gtr:title>Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>585d700b978dc7.24175621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06108A73-F483-428A-BCA3-3737AA7FC3B2</gtr:id><gtr:title>Recommendations for the management of food allergies in a preschool/childcare setting and prevention of anaphylaxis.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a72f016072dd78d6ce724e9052a133"><gtr:id>29a72f016072dd78d6ce724e9052a133</gtr:id><gtr:otherNames>Ford LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>5448f1f6bc6bc7.92688444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28D57534-176C-4A91-B936-028A7FD1C01B</gtr:id><gtr:title>Marked Increase in Basophil Activation during Non-Anaphylactic Allergic Reactions to Peanut in Man</gtr:title><gtr:parentPublicationTitle>Journal of Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3ffa5386909a665d59e0d3e31b6c2e1"><gtr:id>f3ffa5386909a665d59e0d3e31b6c2e1</gtr:id><gtr:otherNames>Turner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5a578b9280ecb7.96065565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82ED59D3-D897-4190-9398-8D62ABC3B8E0</gtr:id><gtr:title>Improving the safety of oral immunotherapy for food allergy.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2a84cf1bb0c252ab42ab50fa8f4de9"><gtr:id>0e2a84cf1bb0c252ab42ab50fa8f4de9</gtr:id><gtr:otherNames>Vazquez-Ortiz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>56a7ed96ae7790.71747213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84A07B56-D03E-41A9-A890-280BB7B6B459</gtr:id><gtr:title>The urgent need for a harmonized severity scoring system for acute allergic reactions.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad87c8910f2f89cb06aef9d8a5ebb5db"><gtr:id>ad87c8910f2f89cb06aef9d8a5ebb5db</gtr:id><gtr:otherNames>Muraro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>5a6f0594d259d7.15991725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D62078-CAD1-4CE2-AC8F-CC96A2B957FB</gtr:id><gtr:title>Food allergy in children: what is new?</gtr:title><gtr:parentPublicationTitle>Current opinion in clinical nutrition and metabolic care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1363-1950</gtr:issn><gtr:outcomeId>5448f2bc525da4.53592411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55D6B5CA-0B72-4B70-BDB3-FCAE4DF1D1A0</gtr:id><gtr:title>How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ff68141c7593a633737da821b8ec63b"><gtr:id>4ff68141c7593a633737da821b8ec63b</gtr:id><gtr:otherNames>Dubois AEJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>5a6f06f7a18e04.11751630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>488AA671-9DE4-4D74-AFDE-72A05DBB3BCD</gtr:id><gtr:title>Implementing Primary Prevention for Peanut Allergy at a Population Level.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>5a5ccde36f2ce3.54467960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F627CD-A2B4-4E69-B892-546AA41DDAE7</gtr:id><gtr:title>Skin testing with raw egg does not predict tolerance to baked egg in egg-allergic children.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>5448f1f5e28673.40404884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E97F33F2-805A-435C-B490-9B4EABC134B8</gtr:id><gtr:title>Striking the balance between primary prevention of allergic disease and optimal infant growth and nutrition.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6545713b67cd36281aefdc69709f992"><gtr:id>c6545713b67cd36281aefdc69709f992</gtr:id><gtr:otherNames>Tan JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>5a2fd5fa8c87d5.49771024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D87EB1F7-9480-46A2-91F4-B9D800443E46</gtr:id><gtr:title>Crossing the threshold: can outcome data from food challenges be used to predict risk of anaphylaxis in the community?</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>585d6541edbb39.16815156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E99B1DAD-8E9C-4D06-86BD-07A585076598</gtr:id><gtr:title>Minimal impact of extensive heating of hen's egg and cow's milk in a food matrix on threshold dose-distribution curves.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb666c8d6a74a59758069afa09a78df4"><gtr:id>cb666c8d6a74a59758069afa09a78df4</gtr:id><gtr:otherNames>Remington BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>5a2fd79268f426.91291189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B65E047C-E145-4511-87E6-557C15F4E5CB</gtr:id><gtr:title>Advice provided by health professionals regarding precautionary allergen labelling.</gtr:title><gtr:parentPublicationTitle>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0905-6157</gtr:issn><gtr:outcomeId>5448f313aced22.65004271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AC0D6EA-4494-4A58-ABDA-C686C103FF22</gtr:id><gtr:title>Dietary management of peanut and tree nut allergy: what exactly should patients avoid?</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d7479da87c295dbb6a12108c74ccf59"><gtr:id>6d7479da87c295dbb6a12108c74ccf59</gtr:id><gtr:otherNames>Brough HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>doi_55faa2aa25098c6d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EACE99BB-D462-4009-8DA3-55B32A95AA0A</gtr:id><gtr:title>Safety and clinical predictors of reacting to extensively heated cow's milk challenge in cow's milk-allergic children.</gtr:title><gtr:parentPublicationTitle>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/666dbff6bce436ca0f6032d6ea3ef784"><gtr:id>666dbff6bce436ca0f6032d6ea3ef784</gtr:id><gtr:otherNames>Mehr S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1081-1206</gtr:issn><gtr:outcomeId>5448f1f656bd90.30390322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6710C44F-269F-4C53-A845-81EDA5CAF88B</gtr:id><gtr:title>Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30cc7c53db4ac24f42cf1cc6fe72ed93"><gtr:id>30cc7c53db4ac24f42cf1cc6fe72ed93</gtr:id><gtr:otherNames>Umasunthar T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>56a7ec7d5ddea3.33099097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513AE944-1385-4288-AB0A-22AFDBBD89FA</gtr:id><gtr:title>Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30cc7c53db4ac24f42cf1cc6fe72ed93"><gtr:id>30cc7c53db4ac24f42cf1cc6fe72ed93</gtr:id><gtr:otherNames>Umasunthar T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>56a7ec7d1cdd16.39235569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C4DFEA-1502-4A31-AA8D-55B8F8C55D4A</gtr:id><gtr:title>Intranasal live-attenuated influenza vaccine (LAIV) is unlikely to cause egg-mediated allergic reactions in egg-allergic children.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675e09a402eb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E008B5-12D5-48CB-8B47-DBADC2E26534</gtr:id><gtr:title>Fatal Anaphylaxis: Mortality Rate and Risk Factors.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a578b7745d013.20719224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>254286F9-C4EA-442D-9B2F-B9AF66CFB05C</gtr:id><gtr:title>A food allergy syndrome by any other name?</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>585d394f954406.30705107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1841B9FF-BB19-490E-A914-555B5EBD8ED2</gtr:id><gtr:title>Allergic gastroenteritis hospital admission time trends in Australia and New Zealand.</gtr:title><gtr:parentPublicationTitle>Journal of paediatrics and child health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6105542f386511b04cd6af69cf31cd7d"><gtr:id>6105542f386511b04cd6af69cf31cd7d</gtr:id><gtr:otherNames>Mullins RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1034-4810</gtr:issn><gtr:outcomeId>5a2fd7837fbd43.84965454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50F001B8-9954-4ED2-A6D3-B64B65AA8C8C</gtr:id><gtr:title>Adherence to extensively heated egg and cow's milk after successful oral food challenge.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8033763ccfe8bc587cd808477d8fa410"><gtr:id>8033763ccfe8bc587cd808477d8fa410</gtr:id><gtr:otherNames>Lee E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56a7ed9710d765.45235740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDBB140F-C7E3-453C-9D5B-EACEC4568568</gtr:id><gtr:title>Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis?</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>585d7008b8c170.60928451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03BC27D-0E3E-44F1-867F-9F49E45E4F4E</gtr:id><gtr:title>Safety of live attenuated influenza vaccine in atopic children with egg allergy.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5675dfc774102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CA5BEB-1278-40C0-A0D7-CDDBFCD3594E</gtr:id><gtr:title>The Emperor Has No Symptoms: The Risks of a Blanket Approach to Using Epinephrine Autoinjectors for All Allergic Reactions.</gtr:title><gtr:parentPublicationTitle>The journal of allergy and clinical immunology. In practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a578badac5f62.90132598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAB340FC-07BD-4AF9-9D72-FCBE77E60066</gtr:id><gtr:title>Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene.</gtr:title><gtr:parentPublicationTitle>Perspectives in public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11718f5eacf544bb4e022cc4070ea922"><gtr:id>11718f5eacf544bb4e022cc4070ea922</gtr:id><gtr:otherNames>Bloomfield SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1757-9147</gtr:issn><gtr:outcomeId>585d700eea2c82.51533800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>216D6EBE-F46D-4BC9-B550-12B4BD07DC7B</gtr:id><gtr:title>Can we identify patients at risk of life-threatening allergic reactions to food?</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>585d60246d2880.79274974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D441E21-FCA1-4490-92F1-B284285CEC10</gtr:id><gtr:title>Acute wheeze in the pediatric population: Case definition &amp;amp; guidelines for data collection, analysis, and presentation of immunization safety data.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50589202c2b2b57653ca5782bbad0"><gtr:id>eed50589202c2b2b57653ca5782bbad0</gtr:id><gtr:otherNames>Katz MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a578bb9305ca9.93022266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC540DAD-2711-4A76-BD19-7D83F9D51F70</gtr:id><gtr:title>Loss of allergenic proteins during boiling explains tolerance to boiled peanut in peanut allergy.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5448f1f6233185.96596226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8752BF1-E6C7-4987-9E7B-24323DB5A7D9</gtr:id><gtr:title>Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f783d23f29317f12815b5467a91d4b"><gtr:id>c4f783d23f29317f12815b5467a91d4b</gtr:id><gtr:otherNames>Turner PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>doi_55faa2aa24fbb36a</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K010468/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>